ESC 365 - Empagliflozin improves renal outcomes in patients with or without heart failure at baseline

Back

HFA Premium Access

Empagliflozin improves renal outcomes in patients with or without heart failure at baseline - insights from the EMPA-REG OUTCOME trial

Session: Patient management - From oral treatment to transplant

Topic: Diabetes and the Heart

Speaker: Professor J. Butler (Dallas, US)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

116 presentations

16 followers

14 more presentations in this session

Structured follow-up program of patients with heart failure: impact on quality of life and prognosis.

Speaker: Doctor J. AGOSTINHO (Lisbon, PT)

Impact of physicians' adherence to guideline-recommended therapy on heart failure re-hospitalizations: data from the Optimize Heart Failure Care Program

Speaker: Doctor A. Grebennikova (Volgograd, RU)

Perceptions of heart failure treatment decision-making and side effects of heart failure treatment by patients and cardiologists: a multinational survey in the real-world cardiology setting

Speaker: Doctor S. Bruce Wirta (Stockholm, SE)

CANCELLED - The effect of home-based cardiac rehabilitation following coronary artery bypass graft surgery in a low income country: A controlled trial

Speaker: Mr J. Uddin (Dhaka, BD)

Access

Abstract

The optimal plasma volume status in heart failure in relation to clinical outcome

Speaker: Doctor P. Martens (Genk, BE)

Access the full session

Patient management - From oral treatment to transplant

Speakers: Professor J. Butler, Doctor J. AGOSTINHO, Doctor A. Grebennikova, Doctor S. Bruce Wirta, Mr J. Uddin...

Access

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources